New MIT Nanotech Fights Cancer Naturally
September 20, 2010 8:30 AM
Harnessing the body's own defense forces to fight cancer with nanoscale technology.
In the myriad advances in treating cancer, many a nanotech study has crossed
path. This week another such study was revealed by the journal
(abstract). In the past, we’ve seen all sorts of man-made nanoparticles both acting as a force of cell destruction and as a ferry, shipping anti-tumor drugs straight to cancer cells where they can be of the most benefit. This latest method by Massachusetts Institute of Technology researchers is akin to the latter, but instead of using nanoparticles to deliver drugs, they deliver modified immune cells from the patient’s own body.
Dr. Darrell Irvine, the team leader for the MIT study, spoke optimistically of the new treatment. “What we're looking for is the extra nudge that could take immune-cell therapy from working in a subset of people to working in nearly all patients, and to take us closer to cures of disease rather than slowing progression.”
The process by which the treatment is administered
. T cells, a type of white blood cell which is involved in cell-mediated immunity, are harvested from the patient’s blood. They are then treated in such a way so that they specifically target cancer cells. The new T cells are then attached to a lipid-based nanoparticle filled with interleukins. Interleukins are a type of chemical that helps promote the growth of T cells. Finally, the T cell and interleukin-laden nanoparticles are injected back into the patient, where the T cells seek out the tumors they’ve been programmed to destroy. The interleukins help maintain a healthy T cell count to combat the cancer cells directly without causing aberrant production elsewhere in the body.
The final part here is important. Interleukin treatments have already been widely tested in cancer patients to promote cancer-fighting T cell growth, but the treatments can have devastating side effects including heart and lung failure. The targeted approach used by Irvine’s group holds the runaway T cell production process in check by only allowing those at the tumor’s area to be affected.
In a trial using mice, the treatment was found to be 100% effective. While standard T cell or T cell and interleukin treatment mice died after 75 days, the control mice died after only 25 days and the mice given the nanoparticle treatment lived on past the 100 day limit of the study.
"It looks like the iPhone 4 might be their Vista, and I'm okay with that." -- Microsoft COO Kevin Turner
PIQ ROBOTTM reveals its new artificial intelligence software
November 29, 2016, 12:59 AM
One more time - Happy Thanksgiving to Everyone Around the World
November 24, 2016, 4:00 AM
Google’s Smart Contact Lens Project gets halted for 2016
November 20, 2016, 7:00 AM
Cell Research Study shows African Americans have greater immune response to infection
November 10, 2016, 1:00 AM
UTHealth Clinical Trial Shows Progress Using Stem Cells to Treat Traumatic Brain Injury
November 8, 2016, 1:00 AM
Uber Partners with Circulation to Pilot Program Connecting Transportation and Digital Health Care
November 6, 2016, 5:00 AM
Most Popular Articles
Sales Battle - Apple iPad Mini vs Samsung Galaxy Tab
November 29, 2016, 12:36 AM
Phillips 55’ 4K Smart TV – Is This Really a Deal? We Think So.
November 25, 2016, 9:44 AM
PlayStation 4 Pro – 4K Console for 4K TVs
November 28, 2016, 1:00 AM
Lenovo Yoga 900 and Lenovo Yogo 900S – Powerful Performance in an Ultra-Thin Packages
November 27, 2016, 5:00 AM
Best Phones of 2016 - Priced under $650.00
November 27, 2016, 5:00 AM
Latest Blog Posts
Dec 3, 2016, 5:00 AM
Dec 2, 2016, 5:00 AM
Surface Ergonomic Keyboard
Dec 1, 2016, 3:01 AM
Chapeconense plane crash: Football rallies around Brazilian Team
Nov 30, 2016, 1:00 AM
How to Extends Your iPhone’s Battery Life
Nov 29, 2016, 12:49 AM
Nov 28, 2016, 1:12 AM
News: Fidel Castro
Nov 27, 2016, 5:00 AM
Nov 26, 2016, 5:00 AM
Changes in Social status affect the way genes turn on and off within immune cells.
Nov 25, 2016, 5:12 AM
Austrian far–right hopeful Hofer may back EU vote.
Nov 24, 2016, 4:00 AM
Final Fantasy XV Leaked Before Nov 29 Launch Date
Nov 23, 2016, 1:00 AM
Nov 22, 2016, 2:26 AM
Nov 21, 2016, 1:00 AM
HTC Makes Big Moves in China
Nov 20, 2016, 2:00 AM
Do you know who is the number one company in the word?
Nov 19, 2016, 5:30 AM
Foldable Cardboard ”EcoHelmet” wins James Dyson Award’s Top Prize
Nov 18, 2016, 2:39 AM
Scientists Discover Roundest Object Ever Spotted in Universe
Nov 17, 2016, 1:00 AM
Smallest Device Lets You Print Almost from Anywhere
Nov 16, 2016, 9:32 AM
Cancer Screening in the Community Is there a link between Cancer and Poverty?
Nov 15, 2016, 8:00 AM
More Blog Posts
Copyright 2016 DailyTech LLC. -
Terms, Conditions & Privacy Information